Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Repeat Administration of Purified Poloxamer 188 (EPIC-E)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02449616
Recruitment Status : Completed
First Posted : May 20, 2015
Last Update Posted : October 28, 2016
Sponsor:
Information provided by (Responsible Party):
Mast Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2016
Study Completion Date : No date given